We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back toSession-3-Scientific-Advice-Where-are-we-now

Value, Access and Regulatory Strategy Workshop


Session 3: Early Dialogue Between Regulators and HTA (and Payers & Patients)